Trials / Completed
CompletedNCT02479139
Clinical Trial To Evaluate ANT-1207 In Participants With Primary Axillary Hyperhidrosis
Clinical Trial to Evaluate ANT-1207 in the Treatment of Primary Axillary Hyperhidrosis in Adults
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 145 (actual)
- Sponsor
- Allergan · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to establish the therapeutic range of ANT-1207 in the treatment of primary axillary hyperhidrosis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Vehicle | Vehicle for ANT-1207 liniment formulation without active ingredient. |
| BIOLOGICAL | ANT-1207 | Botulinum toxin Type A topical liniment (ANT-1207). |
Timeline
- Start date
- 2015-06-03
- Primary completion
- 2016-02-29
- Completion
- 2016-02-29
- First posted
- 2015-06-24
- Last updated
- 2017-09-20
- Results posted
- 2017-09-20
Locations
19 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT02479139. Inclusion in this directory is not an endorsement.